Single cell RNA and immune repertoire profiling of COVID-19 patients reveal novel neutralizing antibody

Fang Li, Meng Luo, Wenyang Zhou, Jinliang Li, Xiyun Jin, Zhaochun Xu, Liran Juan, Zheng Zhang, Yuou Li, Renqiang Liu, Yiqun Li, Chang Xu, Kexin Ma, Huimin Cao, Jingwei Wang, Pingping Wang, Zhigao Bu, Qinghua Jiang

PDF(1673 KB)
PDF(1673 KB)
Protein Cell ›› 2021, Vol. 12 ›› Issue (10) : 751-755. DOI: 10.1007/s13238-020-00807-6
HIGHLIGHT
HIGHLIGHT

Single cell RNA and immune repertoire profiling of COVID-19 patients reveal novel neutralizing antibody

Author information +
History +

Cite this article

Download citation ▾
Fang Li, Meng Luo, Wenyang Zhou, Jinliang Li, Xiyun Jin, Zhaochun Xu, Liran Juan, Zheng Zhang, Yuou Li, Renqiang Liu, Yiqun Li, Chang Xu, Kexin Ma, Huimin Cao, Jingwei Wang, Pingping Wang, Zhigao Bu, Qinghua Jiang. Single cell RNA and immune repertoire profiling of COVID-19 patients reveal novel neutralizing antibody. Protein Cell, 2021, 12(10): 751‒755 https://doi.org/10.1007/s13238-020-00807-6

References

[1]
Cai J, Sun W, Huang J, Gamber M, Wu J, He G (2020) Indirect virus transmission in cluster of COVID-19 cases, Wenzhou, China, 2020. Emerg Infect Dis J 26(6):1343–1345
CrossRef Google scholar
[2]
Cao Y, Su B, Guo X, Sun W, Deng Y, Bao L, Zhu Q, Zhang X, Zheng Y, Geng C (2020) Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients’ B cells. Cell 182:73-84.e16
CrossRef Google scholar
[3]
Gitlin AD, von Boehmer L, Gazumyan A, Shulman Z, Oliveira TY, Nussenzweig MC (2016) Independent roles of switching and hypermutation in the development and persistence of B lymphocyte memory. Immunity 44:769–781
CrossRef Google scholar
[4]
Hu X, Zhang J, Wang J, Fu J, Li T, Zheng X, Wang B, Gu S, Jiang P, Fan J (2019) Landscape of B cell immunity and related immune evasion in human cancers. Nat Genet 51:560–567
CrossRef Google scholar
[5]
Lv Z, Deng Y-Q, Ye Q, Cao L, Sun C-Y, Fan C, Huang W, Sun S, Sun Y, Zhu L (2020) Structural basis for neutralization of SARSCoV-2 and SARS-CoV by a potent therapeutic antibody. Science 369:1505–1509
CrossRef Google scholar
[6]
Palladino G, Mozdzanowska K, Washko G, Gerhard W (1995) Virusneutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice. J Virol 69:2075–2081
CrossRef Google scholar
[7]
Thevarajan I, Nguyen THO, Koutsakos M, Druce J, Caly L, van de Sandt CE, Jia X, Nicholson S, Catton M, Cowie B (2020) Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19. Nat Med 26:453–455
CrossRef Google scholar
[8]
Wang J, Shuai L, Wang C, Liu R, He X, Zhang X, Sun Z, Shan D, Ge J, Wang X(2020) Mouse-adapted SARS-CoV-2 replicates efficiently in the upper and lower respiratory tract of BALB/c and C57BL/6J mice. Protein Cell 11(10):1–7
CrossRef Google scholar
[9]
Wu S, Zhong G, Zhang J, Shuai L, Zhang Z, Wen Z, Wang B, Zhao Z, Song X, Chen Y(2020) A single dose of an adenovirusvectored vaccine provides protection against SARS-CoV-2 challenge. Nat Commun 11:4081
CrossRef Google scholar
[10]
Zou Q, Hu Q, Guo M, Wang G (2015) HAlign: fast multiple similar DNA/RNA sequence alignment based on the centre star strategy. Bioinformatics 31:2475–2481
CrossRef Google scholar

RIGHTS & PERMISSIONS

2020 The Author(s) 2020
AI Summary AI Mindmap
PDF(1673 KB)

Accesses

Citations

Detail

Sections
Recommended

/